# The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)

> **NCT06342752** · — · RECRUITING · sponsor: **University Hospital, Antwerp** · enrollment: 140 (estimated)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DIAGNOSTIC_TEST:** Breath test
- **OTHER:** Throat swabs
- **OTHER:** Placental samples
- **OTHER:** Vaginal swab
- **OTHER:** Endotracheal aspirates

## Key facts

- **NCT ID:** NCT06342752
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-14
- **Primary completion:** 2026-09
- **Final completion:** 2027-09
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06342752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06342752, "The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06342752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*